The human lung cancer cell line A549 transfected with a small interfering (si) RNA-targeting Cx43 was more resistant to a first-line chemotherapy cisplatin than the parental A549 cells (Yu et al., 2014). The gene discussed is GJA1; the disease is lung carcinoma.